HEADLINES

AI smart weighing scale aims to catch disease early

Withings unveils the Body Scan 2 at CES 2026, a $600 AI-powered smart scale that tracks over 60 health biomarkers to help detect risks like high blood pressure and prediabetes early. The device aims to promote healthier aging through advanced data monitoring.

Eric Cox/Reuters

January 09, 2026

A screengrab from the video provided by Reuters featuring Body Scan 2 during the Consumer Electronics Show 2026 in Las Vegas, Nevada on January 7, 2026.

Reuters

French health technology company Withings is betting big on longevity with the debut of the Body Scan 2 at CES in Las Vegas.

The $600 AI-powered smart scale tracks over 60 biomarkers to flag early risks like high blood pressure and prediabetes—catching problems while they’re still fixable, the company says.

With embedded electrodes, a retractable handle and phone syncing, it promises better aging through better data.

“I think that is really good," said Doris Poon, a 72-year-old CES attendee from Maryland who says good health is important to her. "I know so many people don't go to physician and say, 'I am fine. What is fine? How you define fine, right?'"

Withings says the Body Scan 2 will be available in Q2 of 2026.

-Eric Cox/Reuters